| Author (Person) | Jack, Andrew, Tait, Nikki |
|---|---|
| Series Title | Financial Times |
| Series Details | 17.9.08 |
| Publication Date | 17/09/2008 |
| Content Type | News |
|
Big pharmaceutical companies will have to tread very carefully if they try to limit supplies to low-cost markets in Europe in order to prevent their drugs being exported on to higher-cost countries, the European Court of Justice said in an important ruling made on the 16 September 2008. The Court said that if a dominant company refused to meet 'ordinary' orders for medicinal products in order to stop 'parallel exports', it was breaching EU competition law. |
|
| Related Links |
|
| Subject Categories | Business and Industry, Internal Markets, Law |
| Countries / Regions | Europe |